All Articles

Quantum PKI appoints Dr. Judy Gounden as CEO, signaling a strategic push for global growth, crypto-agility, and diverse leadership in digital trust.

With a key FDA meeting set, Trevi Therapeutics pushes its drug Haduvio into late-stage trials, offering hope for millions with no approved treatments.

With record growth and a fortified cash position, ElevateBio combines AI-driven discovery and industrial-scale manufacturing to power the gene therapy boom.

Keystone doubles down on AI advisory with Audax Private Equity's backing, spinning off its supply chain software unit into a new powerhouse, Keystone AI.

With nearly $30M in new funding, fintech firm Obita is building a blockchain-based network to tackle the high costs and delays of global B2B transactions.

The pet franchise doubled its stores in 3 years, achieving $150M in sales. Its rapid rise reflects a booming market and a new competitive landscape.

A new alliance between fintech innovators K1x and Juno promises to automate the most dreaded part of tax season, freeing CPAs from manual data entry.

The opioid treatment specialist projects over $1.1B in revenue, driven by its flagship drug SUBLOCADE and a major strategic overhaul in the U.S.

A new vectorized antibody therapy for ALS, VTx-002, has been granted FDA Fast Track status, accelerating its path to patients battling the disease.

With an expanded Boehringer Ingelheim deal and a new CMO, Enara Bio is set to take its novel 'Dark Antigen' therapy into human trials in 2026.

The medtech firm's preliminary results show a Q4 revenue uptick but miss yearly estimates, signaling a stabilizing but cautious path forward for 2026.

Otis secures a major TfL contract to upgrade 172 escalators, blending a century of history with future-ready tech for a smarter, more reliable commute.

A looming 10-million-ton copper deficit threatens to derail the AI revolution and the green energy transition, sparking a new era of geopolitical competition.

Replicate Bioscience secures major funding to develop next-gen self-replicating RNA vaccines, aiming for more durable and accessible global health solutions.

Cybersecurity firm Corero appoints an award-winning leader to supercharge its partner program, signaling a major push in the competitive DDoS defense market.

With gold hitting record highs, investors are keenly awaiting Kinross's update on three critical US projects that could define its production for a decade.

The special mission aviation provider completes a buyout of Bain Capital, consolidating NTC Group's ownership and securing new capital to expand its services.

With a 432% share price jump and billions in financing lined up, Troilus Gold's Quebec project is becoming a cornerstone of North America's critical minerals.

Calgary-based Horizon Petroleum faces a Management Cease Trade Order over delayed financial filings, raising questions about its European operations.

AI data platform Protege raises its Series A to $65M, tackling the critical data bottleneck with an ethical, licensing-first model for real-world data.